BRUSSELS RELEASES LATEST PHARMA GMP REGULATION

THE EUROPEAN Commission has released a text of the latest secondary regulations underpinning European Union (EU) directive 2001/83/EC on good manufacturing practice for active substances for medicinal products for human use. The latest regulation, approved by the Commission, without reference to the European Parliament and EU ministers, is regulation (EU) No 1252/2014 of May 2014.  See http://ec.europa.eu/health/files/eudralex/vol-1/reg_2014_1252/reg_2014_1252_en.pdf for details.



Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.